The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- Moderna: 4 events in the last 90 days
- Previous: 23 days earlier · Citi tells investors it’s time to sell Moderna after 600%-plus stock gains
What happened
The first Phase 3 data for a cancer vaccine has raised questions about whether the potential new treatment is needed.
Summary assembled by rule from the sources below